Article
Prognostic Nutritional Index (PNI) as a Useful Prognostic Indicator in Patients With HR + HER-2 Negative Metastatic Breast Cancer Treated With CDK 4/6 Inhibitor + Endocrine Therapy
2022-09-28
Abstract excerpt
<h4>Background: </h4> The combination of endocrine therapy and CDK 4/6 inhibitors in the treatment of hormone receptor positive, HER-2 negative metastatic breast cancer resulted in significant increases in survival.In general, the presence of malnutrition in cancer patients is a condition that negatively affects the success of treatment. For this reason, it is important to evaluate the nutritional status of cancer...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d27e9b09-e1d6-5f90-8079-9ad26ea21ef7
- DOI
- 10.21203/rs.3.rs-2079332/v1
